Registered title, quoted from ClinicalTrials.gov
Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer
An open trial on stomach cancer, registered on ClinicalTrials.gov. Led by Southwest Hospital, Army Medical University; 0 other hospitals on this site are listed as study sites.
Status, phase and start date as registered on ClinicalTrials.gov on 8 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.
The study team’s contact details are on the registry record. This site does not pass on enquiries.
Hospitals in mainland China listed for this trial 1
Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.
The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov
Source: ClinicalTrials.gov record NCT06791538, read on 8 Nov 2026; hospital names matched to this site’s hospital list. How names are matched
Checklist for this trial 5
Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.
Show the checklist (5 points)Hide the checklist
18 years to 75 years; sex: all
Registered eligibility fields
Primary gastric lesion histologically confirmed as gastric adenocarcinoma (including papillary adenocarcinoma, tubular adenocarcinoma, mucinous adenocarcinoma, signet ring cell carcinoma, poorly differentiated adenocarcinoma, etc.) via endoscopic biopsy.
Inclusion criterion 2
Preoperative clinical staging as locally advanced gastric cancer (cT2-4a, N0-3, M0) according to the 8th edition of the AJCC TNM staging system.
Inclusion criterion 3
Preoperative ECOG performance status score of 0 or 1.
Inclusion criterion 5
Pregnant or breastfeeding women.
Exclusion criterion 14
Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: earlier treatment; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes.
Questions to ask the study team
Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT06791538, read on 10 Nov 2026.
Registered criteria
Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.
Inclusion Criteria:
- Age > 18 years and < 75 years.
- Primary gastric lesion histologically confirmed as gastric adenocarcinoma (including papillary adenocarcinoma, tubular adenocarcinoma, mucinous adenocarcinoma, signet ring cell carcinoma, poorly differentiated adenocarcinoma, etc.) via endoscopic biopsy.
- Preoperative clinical staging as locally advanced gastric cancer (cT2-4a, N0-3, M0) according to the 8th edition of the AJCC TNM staging system.
- No distant metastasis on preoperative examination, and no direct invasion of the pancreas, spleen, or other adjacent organs.
- Preoperative ECOG performance status score of 0 or 1.
- Preoperative ASA (American Society of Anesthesiologists) physical status score of I-III.
- Consent to participate in the study and signing of the informed consent form.
Exclusion Criteria:
- Previous history of gastric malignancy surgery, including submucosal resection and/or endoscopic mucosal resection.
- History of upper abdominal surgery (excluding laparoscopic cholecystectomy).
- Preoperative imaging shows regional lymph nodes with confluent enlargement (maximum diameter ≥3cm).
- Patient underwent emergency surgery due to gastric tumor bleeding or perforation.
- History of other malignancies, or presence of other malignant tumors detected during preoperative examination.
- Patient has a history of malignant tumor, or other malignant tumors were found during preoperative examination
- ASA (American Society of Anesthesiologists) score >3.
- Severe psychiatric disorders.
- History of unstable angina or myocardial infarction within the past 6 months.
- History of cerebral infarction or cerebral hemorrhage within the past 6 months.
- Severe pulmonary disease with FEV1 < 50%.
- Systemic corticosteroid therapy within 1 month prior to the study.
- Need for concurrent surgery for other diseases.
- Pregnant or breastfeeding women.
Quoted from ClinicalTrials.gov, NCT06791538, participation criteria. Read on 10 Nov 2026.
Where this information comes from
The registry record
ClinicalTrials.gov (US National Library of Medicine), record NCT06791538, read on 8 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.
Diseases and hospitals
The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions
What is left out
Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.